Clinical trial
Effect of Pancreatic Enzyme Replacement Therapy in Patients With Acute Necrotizing Pancreatitis: A Multicenter Double Blinded Randomised Placebo Controlled Trial
NCT07441824 is registered in ClinicalTrials.gov with Asian Institute of Gastroenterology, India as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Pancreatic Enzyme Replacement Therapy in Patients With Acute Necrotizing Pancreatitis: A Multicenter Double Blinded Randomised Placebo Controlled Trial
- Lead sponsor
- Asian Institute of Gastroenterology, India
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- April 10, 2026
- Completion date
- June 30, 2027
- Enrollment
- 140 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
acute necrotizing pancreatitis, pancreatic exocrine insufficiency